Latest filings (excl ownership)
8-K
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
13 Mar 24
10-Q
2024 Q2
Quarterly report
13 Mar 24
8-K
Departure of Directors or Certain Officers
27 Feb 24
8-K
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
1 Feb 24
DEFR14A
Revised proxy
21 Dec 23
ARS
2023 FY
Annual report to shareholders
21 Dec 23
10-Q
2024 Q1
Quarterly report
15 Dec 23
10-K/A
2023 FY
Annual report (amended)
28 Nov 23
10-K
2023 FY
Annual report
3 Nov 23
NT 10-K
Notice of late annual filing
30 Oct 23
8-K
Departure of Directors or Certain Officers
30 Oct 23
8-K
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
6 Sep 23
8-K/A
Financial Statements and Exhibits
28 Jul 23
8-K
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
24 Jul 23
EFFECT
Notice of effectiveness
19 Jul 23
424B3
Prospectus supplement
18 Jul 23
S-3/A
Shelf registration (amended)
18 Jul 23
CORRESP
Correspondence with SEC
18 Jul 23
CORRESP
Correspondence with SEC
18 Jul 23
8-K
Other Events
17 Jul 23
UPLOAD
Letter from SEC
14 Jul 23
S-3/A
Shelf registration (amended)
10 Jul 23
8-K
Entry into a Material Definitive Agreement
10 Jul 23
CORRESP
Correspondence with SEC
10 Jul 23
UPLOAD
Letter from SEC
28 Jun 23
EFFECT
Notice of effectiveness
22 Jun 23
424B3
Prospectus supplement
21 Jun 23
CORRESP
Correspondence with SEC
20 Jun 23
S-3/A
Shelf registration (amended)
16 Jun 23
S-3
Shelf registration
16 Jun 23
8-K
Other Events
16 Jun 23
10-Q
2023 Q3
Quarterly report
14 Jun 23
NT 10-Q
Notice of late quarterly filing
9 Jun 23
CORRESP
Correspondence with SEC
9 Jun 23
D
$7.00 mm in options, sold $7.00 mm, 3 investors
2 Jun 23
8-K
Other Events
30 May 23
S-3/A
Shelf registration (amended)
26 May 23
8-K
Submission of Matters to a Vote of Security Holders
22 May 23
8-K
Entry into a Material Definitive Agreement
22 May 23
UPLOAD
Letter from SEC
22 May 23
Latest ownership filings
4
Kara Cannon
27 Feb 24
4
Patricia Eckert
27 Feb 24
SC 13G/A
1 MAIN CAPITAL MANAGEMENT, LLC
14 Feb 24
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
4
STEVEN J PULLY
2 Feb 24
4
MARY TAGLIAFERRI
2 Feb 24
4
Bradley Louis Radoff
2 Feb 24
4
STEVEN J PULLY
15 Dec 23
3
STEVEN J PULLY
30 Oct 23
SC 13G
1 MAIN CAPITAL MANAGEMENT, LLC
11 Sep 23
4
Kara Cannon
5 Sep 23
SC 13D/A
LABORATORY CORP OF AMERICA HOLDINGS
24 Jul 23
11-K
Annual report of employee stock purchases
29 Jun 23
4
Patricia Eckert
31 May 23
SC 13D/A
Radoff Bradley Louis
10 May 23
SC 13D
LABORATORY CORP OF AMERICA HOLDINGS
27 Mar 23
4
James G. Wolf
13 Feb 23
4
Ian B. Walters
13 Feb 23
4
MARY TAGLIAFERRI
13 Feb 23
4
Bradley Louis Radoff
13 Feb 23
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 23
4
Kara Cannon
31 Jan 23
4
James G. Wolf
30 Jan 23
SC 13D/A
Wolf James G.
23 Jan 23
4
James G. Wolf
23 Jan 23
4
James G. Wolf
19 Jan 23
3/A
James G. Wolf
18 Jan 23
3/A
James G. Wolf
12 Jan 23
3
James G. Wolf
9 Jan 23
4
Hamid Erfanian
28 Nov 22
4
Kara Cannon
28 Nov 22
SC 13D/A
Wolf James G.
23 Nov 22
3
Patricia Eckert
15 Nov 22
SC 13D/A
Wolf James G.
26 Oct 22
4
Kara Cannon
19 Jul 22
4
MARY TAGLIAFERRI
14 Jul 22
4
Ian B. Walters
14 Jul 22
4
Bradley Louis Radoff
14 Jul 22
4
Bradley Louis Radoff
13 Jul 22
4
Bradley Louis Radoff
6 Jul 22